source name	characteristics[organism]	characteristics[organism part]	characteristics[brodmann area]	characteristics[cell type]	characteristics[age]	characteristics[ancestry category]	characteristics[sex]	characteristics[disease]	characteristics[developmental stage]	characteristics[BRAAK]	characteristics[PMD]	characteristics[biological replicate]	characteristics[APOE]	characteristics[CERAD]	characteristics[comorbidity]	characteristics[individual]	assay name	technology type	comment[proteomexchange accession number]	comment[data file]	comment[file url]	comment[fraction identifier]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[cleavage agent details]	comment[label]	comment[fragment mass tolerance]	comment[precursor mass tolerance]	comment[technical replicate]	factor value[disease]	factor value[sex]
PXD018855-Sample-1	Homo sapiens	Brain	Brodmann area 8/9	not applicable	90	not available	male	Normal	adult	1	21	1	e3/e3	not applicable	not applicable	1	run 1	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_2097.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_2097.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Normal	male
PXD018855-Sample-2	Homo sapiens	Brain	Brodmann area 8/9	not applicable	73	not available	male	Alzheimer's disease	adult	6	24	1	e3/e4	C def	Parkinson's disease	2	run 2	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_1741.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_1741.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-3	Homo sapiens	Brain	Brodmann area 8/9	not applicable	90	not available	female	Alzheimer's disease	adult	6	9	1	e3/e4	C def	Infarct	3	run 3	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_2056.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_2056.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	female
PXD018855-Sample-4	Homo sapiens	Brain	Brodmann area 8/9	not applicable	76	not available	male	Alzheimer's disease	adult	5	12	1	e3/e4	C def	"Lewy body dementia, CerebroVascular Disease"	4	run 4	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_2027_rerun.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_2027_rerun.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-5	Homo sapiens	Brain	Brodmann area 8/9	not applicable	90	not available	male	Alzheimer's disease	adult	6	23	1	e3/e4	B pro	"CerebroVascular Disease, Cerebral Amyloid Angiopathy"	5	run 5	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_1862.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_1862.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-6	Homo sapiens	Brain	Brodmann area 8/9	not applicable	90	not available	female	Alzheimer's disease	adult	5	7	1	e3/e4	B pro	Lewy body dementia	6	run 6	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_2100.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_2100.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	female
PXD018855-Sample-7	Homo sapiens	Brain	Brodmann area 8/9	not applicable	85	not available	female	Alzheimer's disease	adult	5	24	1	e3/e4	B pro	not applicable	7	run 7	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_2021_rerun.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_2021_rerun.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	female
PXD018855-Sample-8	Homo sapiens	Brain	Brodmann area 8/9	not applicable	90	not available	female	Alzheimer's disease	adult	6	24	1	e3/e4	C def	not applicable	8	run 8	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_2130_rerun.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_2130_rerun.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	female
PXD018855-Sample-9	Homo sapiens	Brain	Brodmann area 8/9	not applicable	85	not available	male	Alzheimer's disease	adult	6	24	1	e3/e4	C def	not applicable	9	run 9	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_2122.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_2122.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-10	Homo sapiens	Brain	Brodmann area 8/9	not applicable	89	not available	male	Alzheimer's disease	adult	6	6	1	e3/e3	C def	CerebroVascular Disease	10	run 10	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_1889.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_1889.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-11	Homo sapiens	Brain	Brodmann area 8/9	not applicable	60	not available	female	Alzheimer's disease	adult	6	24	1	e3/e3	B pro	not applicable	11	run 11	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_1628_rerun.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_1628_rerun.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	female
PXD018855-Sample-12	Homo sapiens	Brain	Brodmann area 8/9	not applicable	86	not available	male	Alzheimer's disease	adult	6	20	1	e3/e3	C def	not applicable	12	run 12	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_1636.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_1636.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-13	Homo sapiens	Brain	Brodmann area 8/9	not applicable	84	not available	male	Alzheimer's disease	adult	5	13	1	e3/e4	C def	not applicable	13	run 13	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_2104.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_2104.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-14	Homo sapiens	Brain	Brodmann area 8/9	not applicable	64	not available	female	Alzheimer's disease	adult	6	16	1	e3/e4	C def	Cerebral Amyloid Angiopathy	14	run 14	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_1794.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_1794.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	female
PXD018855-Sample-15	Homo sapiens	Brain	Brodmann area 8/9	not applicable	87	not available	female	Alzheimer's disease	adult	6	4	1	e3/e4	C def	Cerebral Amyloid Angiopathy	15	run 15	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_2124.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_2124.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	female
PXD018855-Sample-16	Homo sapiens	Brain	Brodmann area 8/9	not applicable	67	not available	male	Alzheimer's disease	adult	6	16	1	e3/e2	C def	Lewy body dementia	16	run 16	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_1851.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_1851.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-17	Homo sapiens	Brain	Brodmann area 8/9	not applicable	82	not available	male	Alzheimer's disease	adult	6	16	1	e3/e4	B pro	Hippocampal Sclerosis	17	run 17	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_1896.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_1896.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-18	Homo sapiens	Brain	Brodmann area 8/9	not applicable	89	not available	male	Alzheimer's disease	adult	6	24	1	e3/e3	C def	not applicable	18	run 18	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_2017_rerun.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_2017_rerun.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-19	Homo sapiens	Brain	Brodmann area 8/9	not applicable	77	not available	male	Alzheimer's disease	adult	6	30	1	e4/e4	B pro	not applicable	19	run 19	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_1684.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_1684.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-20	Homo sapiens	Brain	Brodmann area 8/9	not applicable	84	not available	male	Alzheimer's disease	adult	6	40	1	e3/e4	C def	not applicable	20	run 20	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_2059.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_2059.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-21	Homo sapiens	Brain	Brodmann area 8/9	not applicable	90	not available	male	Alzheimer's disease	adult	6	12	1	e3/e3	B pro	not applicable	21	run 21	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_1564_rerun.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_1564_rerun.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-22	Homo sapiens	Brain	Brodmann area 8/9	not applicable	86	not available	male	Alzheimer's disease	adult	6	24	1	e3/e4	B pro	not applicable	22	run 22	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_2102_rerun.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_2102_rerun.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-23	Homo sapiens	Brain	Brodmann area 8/9	not applicable	81	not available	male	Alzheimer's disease	adult	6	23	1	e3/e4	B pro	not applicable	23	run 23	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_2151.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_2151.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-24	Homo sapiens	Brain	Brodmann area 8/9	not applicable	75	not available	female	Alzheimer's disease	adult	6	18	1	e3/e4	B pro	not applicable	24	run 24	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_1648_rerun.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_1648_rerun.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	female
PXD018855-Sample-25	Homo sapiens	Brain	Brodmann area 8/9	not applicable	67	not available	male	Alzheimer's disease	adult	6	28	1	e3/e4	C def	not applicable	25	run 25	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_1892.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_1892.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-26	Homo sapiens	Brain	Brodmann area 8/9	not applicable	63	not available	female	Alzheimer's disease	adult	6	28	1	e3/e4	C def	PS2 mutation	26	run 26	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_2157.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_2157.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	female
PXD018855-Sample-27	Homo sapiens	Brain	Brodmann area 8/9	not applicable	72	not available	male	Alzheimer's disease	adult	6	24	1	e3/e3	B pro	not applicable	27	run 27	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_1566_rerun.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_1566_rerun.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-28	Homo sapiens	Brain	Brodmann area 8/9	not applicable	58	not available	female	Alzheimer's disease	adult	6	12	1	e3/e4	C def	Cerebral Amyloid Angiopathy	28	run 28	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_1791_rerun.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_1791_rerun.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	female
PXD018855-Sample-29	Homo sapiens	Brain	Brodmann area 8/9	not applicable	76	not available	male	Alzheimer's disease	adult	6	22	1	e3/e4	B pro	"CerebroVascular Disease, Cerebral Amyloid Angiopathy"	29	run 29	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_1971_rerun.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_1971_rerun.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-30	Homo sapiens	Brain	Brodmann area 8/9	not applicable	84	not available	male	Alzheimer's disease	adult	6	21	1	e4/e4	C def	"Lewy body dementia, CerebroVascular Disease"	30	run 30	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_1912.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_1912.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male
PXD018855-Sample-31	Homo sapiens	Brain	Brodmann area 8/9	not applicable	83	not available	female	Alzheimer's disease	adult	6	38	1	e4/e4	C def	"Lewy body dementia, CerebroVascular Disease"	31	run 31	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_1853_rerun.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_1853_rerun.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	female
PXD018855-Sample-32	Homo sapiens	Brain	Brodmann area 8/9	not applicable	84	not available	male	Alzheimer's disease	adult	6	7	1	e4/e4	A pos	not applicable	32	run 32	proteomic profiling by mass spectrometry	PXD018855	20190412_PB_MGH_progression_2014.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2020/08/PXD018855/20190412_PB_MGH_progression_2014.raw	1	AC=MS:1001911;NT=Q Exactive	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=Fixed	NT=Oxidation;MT=Variable;TA=M;AC=UNIMOD:35	AC=MS:1001251;NT=Trypsin	not applicable	0.02 Da	10 ppm	1	Alzheimer's disease	male